These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3051271)

  • 21. [Medical disability expertise and the rehabilitation of pancreatitis patients].
    Mitropol'skiĭ AN; Babinina VF
    Sov Med; 1985; (10):61-4. PubMed ID: 2934827
    [No Abstract]   [Full Text] [Related]  

  • 22. [Lung adenocarcinoma, monoclonal gammapathy and scleroderma].
    Camps García MT; Domenech del Río I; Belmonte López A; Fernández Nebro A; Ramón Garrido E
    An Med Interna; 1991 Apr; 8(4):207-8. PubMed ID: 1912184
    [No Abstract]   [Full Text] [Related]  

  • 23. [Scleroderma as a systemic disease in dermatological practice].
    Ziprkowski L; Feinstein A
    Harefuah; 1970 Apr; 78(7):344-9. PubMed ID: 5495231
    [No Abstract]   [Full Text] [Related]  

  • 24. [Association of generalized scleroderma with a chronic hepatic disorder. 2 additional cases].
    Buffet C; Fanjoux J; Auperin A; Chaput JC; Regensberg M; Etienne JP
    Nouv Presse Med; 1974 Dec; 3(45):2715-6. PubMed ID: 4549262
    [No Abstract]   [Full Text] [Related]  

  • 25. [Comparative study of focal (skin) and systemic forms of scleroderma].
    Monakhov KN; Raznatovskiĭ IM
    Revmatologiia (Mosk); 1988; (3):36-9. PubMed ID: 3065893
    [No Abstract]   [Full Text] [Related]  

  • 26. Responsiveness of the SF-36 and the Health Assessment Questionnaire Disability Index in a systemic sclerosis clinical trial.
    Khanna D; Furst DE; Clements PJ; Park GS; Hays RD; Yoon J; Korn JH; Merkel PA; Rothfield N; Wigley FM; Moreland LW; Silver R; Steen VD; Weisman M; Mayes MD; Collier DH; Medsger TA; Seibold JR; ;
    J Rheumatol; 2005 May; 32(5):832-40. PubMed ID: 15868618
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systemic scleroderma (a report of four cases).
    Vyas PJ; Acharya KM
    J Assoc Physicians India; 1981 Jul; 29(7):555-9. PubMed ID: 7328079
    [No Abstract]   [Full Text] [Related]  

  • 28. [Clinical aspects of progressive systemic scleroderma (PSS). Multicenter studies of 194 patients].
    Goerz G; Hammer G; Wirth G; Hornstein OP; Keller GJ; Altmeyer P; Holzmann H; Meigel W; Mensing H; Braun-Falco O
    Hautarzt; 1986 Jun; 37(6):320-4. PubMed ID: 3522484
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patient preference disability questionnaire in systemic sclerosis: a cross-sectional survey.
    Mouthon L; Rannou F; Bérezné A; Pagnoux C; Guilpain P; Goldwasser F; Revel M; Guillevin L; Fermanian J; Poiraudeau S
    Arthritis Rheum; 2008 Jul; 59(7):968-73. PubMed ID: 18576298
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Variants of the course of systemic scleroderma].
    Guseva NG
    Vopr Revm; 1967; 7(4):57-61. PubMed ID: 5620725
    [No Abstract]   [Full Text] [Related]  

  • 31. [Developing a clinical classification of systemic scleroderma].
    Guseva NG
    Vopr Revm; 1969; 9(2):14-8. PubMed ID: 5363860
    [No Abstract]   [Full Text] [Related]  

  • 32. [Evaluation of immunological processes in expert testimony regarding disability in rheumatologic diseases].
    Morozova RZ; Pentiuk AA
    Vrach Delo; 1980 Mar; (3):58-60. PubMed ID: 7376615
    [No Abstract]   [Full Text] [Related]  

  • 33. [Development of criteria for diagnosing systemic scleroderma].
    Guseva NG
    Vopr Revm; 1968; 8(3):52-7. PubMed ID: 5742388
    [No Abstract]   [Full Text] [Related]  

  • 34. Reliability and validity of the Duruoz Hand Index in persons with systemic sclerosis (scleroderma).
    Brower LM; Poole JL
    Arthritis Rheum; 2004 Oct; 51(5):805-9. PubMed ID: 15478150
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Characteristics of the clinical course of systemic scleroderma].
    Iashchenko OB
    Vrach Delo; 1984 Sep; (9):88-92. PubMed ID: 6506654
    [No Abstract]   [Full Text] [Related]  

  • 36. [Sclerodermatomyositis. Apropos of 13 cases].
    Guiziou C; Lebreton C; Kaplan G; Vigneron AM; Kahn MF
    Rev Rhum Mal Osteoartic; 1987 Jun; 54(6):457-61. PubMed ID: 3616470
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [News about scleroderma: survey of present state of research problems (author's transl)].
    Stáva Z; Kobíková M; Kolár J; Drugová B
    Cas Lek Cesk; 1974; 113(26):787-92. PubMed ID: 4844781
    [No Abstract]   [Full Text] [Related]  

  • 38. Assessing disability and quality of life in systemic sclerosis: construct validities of the Cochin Hand Function Scale, Health Assessment Questionnaire (HAQ), Systemic Sclerosis HAQ, and Medical Outcomes Study 36-Item Short Form Health Survey.
    Rannou F; Poiraudeau S; Berezné A; Baubet T; Le-Guern V; Cabane J; Guillevin L; Revel M; Fermanian J; Mouthon L
    Arthritis Rheum; 2007 Feb; 57(1):94-102. PubMed ID: 17266096
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pseudosclerodermic conditions].
    Guseva NG; Akimova TF; Akhnazarova VD; Oskilko TG
    Ter Arkh; 1976; 48(11):13-9. PubMed ID: 1021889
    [No Abstract]   [Full Text] [Related]  

  • 40. [Clinico-immunological characteristics of the course of systemic scleroderma].
    Musaev SK; Speranskiĭ AI
    Ter Arkh; 1984; 56(5):42-5. PubMed ID: 6611599
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.